Is TherapeuticsMD, Inc. (TXMD) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 27.6% / 30% | 19.4% / 30% | 13.7% / 30% | 65.25% / 5% | ✗ NOT HALAL |
| DJIM | 27.6% / 33% | 19.4% / 33% | 13.7% / 33% | 65.25% / 5% | ✗ NOT HALAL |
| MSCI | 18.5% / 33% | 13.0% / 33% | 9.2% / 33% | 65.25% / 5% | ✗ NOT HALAL |
| S&P | 27.6% / 33% | 19.4% / 33% | 13.7% / 33% | 65.25% / 5% | ✗ NOT HALAL |
| FTSE | 18.5% / 33% | 13.0% / 33% | 9.2% / 50% | 65.25% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 100.0% | |
| Operating Margin | -37.8% | |
| Net Margin | 10.8% | |
| Return on Equity (ROE) | 0.3% | |
| Return on Assets (ROA) | -2.7% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $1M |
| Free Cash Flow | $1M |
| Total Debt | $7M |
| Debt-to-Equity | 23.6 |
| Current Ratio | 2.9 |
| Total Assets | $39M |
Price & Trading
| Last Close | $2.22 |
| 50-Day MA | $2.30 |
| 200-Day MA | $1.56 |
| Avg Volume | 81K |
| Beta | 0.5 |
|
52-Week Range
$0.84
| |
About TherapeuticsMD, Inc. (TXMD)
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is TherapeuticsMD, Inc. (TXMD) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), TherapeuticsMD, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is TherapeuticsMD, Inc.'s debt ratio?
TherapeuticsMD, Inc.'s debt ratio is 27.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 18.5%.
What are TherapeuticsMD, Inc.'s key financial metrics?
TherapeuticsMD, Inc. has a market capitalization of $24M, trailing P/E ratio of 210.0, and revenue of $2M. The company maintains a gross margin of 100.0% and a net margin of 10.8%. Return on equity stands at 0.3%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.